Powered by Fragmos Chain, Elaris OTC is a technology platform that enables seamless and fully automated matching of OTC derivatives trades and lifecycle events between market participants, and achieves interoperability by translating native client messaging formats into the Common Domain Model (CDM) standard. This allows institutions to reduce operational costs and risk significantly while supporting all asset classes and lifecycle events.
Crucially, Elaris OTC is more than just a platform: it can be combined with Delta Capita’s global OTC confirmation and settlement services to extend automation beyond platform participants. This combination enables users to capture and manage interactions with all counterparties – whether or not they use the platform, and leverages Delta Capita’s established service model to deliver straight-through processing and control across the full spectrum of post-trade activity.
As the trade evolves the platform captures lifecycle events using ISDA CDM logic. It then matches these events between counterparties, ensuring both sides agree, ensuring a continuously synchronised and auditable record of the trade lifecycle.
Matches the trade details bilaterally between counterparties and creates a single, golden record of the trade, immutably recorded on a private blockchain, visible and verifiable by both parties.
Match and agree lifecycle events with counterparties not on the platform and resolve exceptions, leveraging Delta Capita’s specialist OTC Settlements and lifecycle management expertise.
Acts as a translation layer, converting each bank’s proprietary trade into the ISDA Common Domain Model (CDM) ensuring a standardised, machine-readable representation for consistency across institutions, reducing ambiguity and manual intervention.
Bring manually confirmed trades onto the ElarisOTC platform and manage exceptions, leveraging Delta Capita’s specialist OTC confirmation experts capturing all activity onto the platform whilst retaining full audit trail and documentation.
